Proviral Latency, Persistent Human Immunodeficiency Virus Infection, and the Development of Latency Reversing Agents. - Wikidata - wikimedia - TriplyDB

Proviral Latency, Persistent Human Immunodeficiency Virus Infection, and the Development of Latency Reversing Agents.

Proviral Latency, Persistent Human Immunodeficiency Virus Infection, and the Development of Latency Reversing Agents.

http://www.wikidata.org/entity/Q39315697

about

Eradication of HIV from Tissue Reservoirs: Challenges for the Cure.Evaluation of the innate immune modulator acitretin as a strategy to clear the HIV reservoir.FISHing Out the Hidden Enemy: Advances in Detecting and Measuring Latent HIV-Infected Cells.Role of Monocyte/Macrophages during HIV/SIV Infection in Adult and Pediatric Acquired Immune Deficiency Syndrome.Digital PCR as a tool to measure HIV persistence.Trade-off between synergy and efficacy in combinations of HIV-1 latency-reversing agents.Development of sensitive ddPCR assays to reliably quantify the proviral DNA reservoir in all common circulating HIV subtypes and recombinant forms Evidence for persistence of the SHIV reservoir early after MHC haploidentical hematopoietic stem cell transplantation Insight into treatment of HIV infection from viral dynamics models Combination anti-PD-1 and antiretroviral therapy provides therapeutic benefit against SIV

P2860

Q38660421-D3B827CD-C6E4-47A1-AEB1-088370D5B307 Q40056964-5A2816C2-38E8-4ED3-9F00-DFC84597A6F8 Q41676254-1C635D2E-0D01-4FE3-9D9D-1E46C0CE0642 Q47100536-F409F637-0DE4-49F1-85F3-5A9F965946BD Q47548213-586B9B32-301B-4D0C-AB9F-5C0EE441AC53 Q49925023-DC8E2A59-F0C4-49BD-ADAB-5CC06C45BF84 Q58128506-3AF934AD-E81B-4E2E-BA9A-1C81A2367C21 Q58561116-20E42508-CFF1-4C00-BCF7-35BCABB173C5 Q58788145-A913F7D3-90C1-465A-9D60-13938E256773 Q59125545-308CB503-8C67-4745-A9FE-7821E95EDA2B

P2860

Proviral Latency, Persistent Human Immunodeficiency Virus Infection, and the Development of Latency Reversing Agents.

http://www.wikidata.org/entity/Q39315697

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Proviral Latency, Persistent H ...... t of Latency Reversing Agents.

@en

Proviral Latency, Persistent H ...... t of Latency Reversing Agents.

@nl

type

label

Proviral Latency, Persistent H ...... t of Latency Reversing Agents.

@en

Proviral Latency, Persistent H ...... t of Latency Reversing Agents.

@nl

prefLabel

Proviral Latency, Persistent H ...... t of Latency Reversing Agents.

@en

Proviral Latency, Persistent H ...... t of Latency Reversing Agents.

@nl

P1433

Q39315697-CB6E0CA1-BDAF-4766-BC47-8FFBBE9869C2

P1476

Q39315697-F38AEA5E-16D7-45AE-A295-3F06D3118B46

P2093

Q39315697-EEC83799-FED3-4162-BD8A-1881D1C15088

P2860

Q39315697-03B212DA-AF2F-43F2-813D-5F6DCD403251

Q39315697-0545B065-7EA6-4F05-875A-2786FFE1F833

Q39315697-06044033-4522-4D39-9874-F3D62E6BB65E

Q39315697-06E5EDE0-5230-46DC-9853-46C9695DB1A4

Q39315697-070AECAA-C0B4-4DCC-8E29-CA65AF9A721A

Q39315697-0A7024DF-FE52-4F3C-A8C5-1BACC816C6D5

Q39315697-0F35A580-EBFD-4FA6-BDE7-81916DD55395

Q39315697-0FE46F45-2EC4-4BBB-8C22-6808386827FC

Q39315697-10E735B9-AFD8-4AD4-B353-809D0B03C08F

Q39315697-11D4F5E0-42AB-43AB-A160-10526E2B3A6A

P304

Q39315697-1EB6BDE4-8181-4E87-A341-040A67DE70D2

P31

Q39315697-B0E2ED86-9954-425B-BB2A-F747463B7DF5

P356

Q39315697-CD91D707-6CFC-4B57-BB58-20DDA7946AAA

P407

Q39315697-8C437BA6-1404-48B0-82E4-BD15F945DAC4

P433

Q39315697-9092CE12-5C3B-4A51-8115-5ED95A6D74F4

P478

Q39315697-6D8129F4-497E-4D74-847F-EB685B338211

P50

Q39315697-A6C9A694-3E25-4AE6-A068-13BED6A7E0C1

P577

Q39315697-A20068FE-7DC4-4E2E-AC0A-9F9C05B51151

P698

Q39315697-3218C9EC-DB57-4DB2-8AED-18495129F41B

P932

Q39315697-0FEEBCC2-9866-4752-9388-9E3C10754AA5

P356

P1433

The Journal of Infectious Diseases

P1476

Proviral Latency, Persistent H ...... nt of Latency Reversing Agents

@en

P2093

Nancie M Archin

http://www.w3.org/2001/XMLSchema#string

P2860

Translating the Histone Code

Recruitment of chromatin-modifying enzymes by CTIP2 promotes HIV-1 transcriptional silencing

Expression of latent HIV induced by the potent HDAC inhibitor suberoylanilide hydroxamic acid

Suberoylanilide hydroxamic acid reactivates HIV from latently infected cells

The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic

Histone deacetylase inhibitors impair the elimination of HIV-infected cells by cytotoxic T-lymphocytes

The language of covalent histone modifications

Depletion of latent HIV-1 infection in vivo: a proof-of-concept study

Clinical development of histone deacetylase inhibitors as anticancer agents

The T cell activation factor NF-ATc positively regulates HIV-1 replication and gene expression in T cells

P304

S111-S118

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/INFDIS/JIW618

http://www.w3.org/2001/XMLSchema#string

P407

P433

suppl_3

http://www.w3.org/2001/XMLSchema#string

P478

215

http://www.w3.org/2001/XMLSchema#string

P50

David M. Margolis

P577

2017-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28520964

http://www.w3.org/2001/XMLSchema#string

P932

5410986

http://www.w3.org/2001/XMLSchema#string